Loading clinical trials...

Pre-mapping Networks for Brain Stimulation 2 | Clinical Trials | Clareo Health

COMPLETEDNANCT05260086

Pre-mapping Networks for Brain Stimulation 2

The investigators compare the primary and secondary outcome measures using accelerated intermittent theta burst stimulation (aiTBS, 20 sessions active and 20 sessions sham in a counterbalanced crossov...

Lead sponsor: University Medical Center Goettingen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

Ketamine Augmentation of ECT in Treatment-Resistant Depression

NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression

RECRUITINGPhase 2

Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

NCT06843187 · Major Depressive Disorder(MDD), Insomnia Comorbid to Psychiatric Disorder

RECRUITINGPhase 3

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

NCT06564818 · Major Depressive Disorder

RECRUITINGNA

RESISTance Exercise for Depression Trial

NCT06110897 · Major Depressive Disorder

RECRUITINGPhase 1/2

Neural Response to Inflammatory Challenge in Major Depressive Disorder

NCT04751331 · Major Depressive Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 19, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment92

Start dateApr 2019

Last updatedMay 19, 2022

Condition

Depressive Episode Major Depressive Disorder

Locations shown

Laboratory of Systems Neuroscience and Imaging in Psychiatry (SNIP-Lab Göttingen)

Göttingen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 19, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions